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Background: Few randomized controlled trials (RCTs) report interventions targeting improvement of frailty status
as an outcome.
Methods: This RCT enrolled 117 older adults (65-79 years of age) in Toufen, Taiwan who scored 3-6 on The Chinese
Canadian Study of Health and Aging Clinical Frailty Scale Telephone Version and then score ≥1 on the
Cardiovascular Health Study Phenotypic Classification of Frailty (CHS_PCF). With a two by two factorial design,
subjects were randomly assigned to interventions (Exercise and nutrition, EN, n = 55 or problem solving therapy,
PST, n = 57) or controls (non-EN, n = 62 or non-PST, n = 60). Educational booklets were provided to all. EN group
subjects received nutrition consultation and a thrice-weekly exercise-training program while PST group subjects
received 6 sessions in 3 month. Subjects were followed at 3, 6, and 12 months. Primary outcome was improvement
of the CHS_PCF by at least one category (from pre-frail to robust, or from frail to pre-frail or robust) from baseline
assessments. One hundred and one completed final assessments. Intention-to-treat analysis with the generalized
estimating equation model was applied with adjustment for time and treatment-by-time interactions.
Results: Mean age was 71.4 ± 3.7 years, with 59% females. Baseline characteristic were generally comparable
between groups. EN group subjects had a higher improvement rate on the primary outcome than non-EN group
subjects (45% vs 27%, adjusted p = 0.008) at 3 months, but not 6 or 12 months. They also had more increase of
serum 25(OH) vitamin D level (4.9 ± 7.7 vs 1.2 ± 5.4, p = 0.006) and lower percentage of osteopenia (74% vs 89%
p= 0.042) at 12 months. PST group subjects had better improvement (2.7 ± 6.1 vs 0.2 ± 6.7, p = 0.035, 6-month) and
less deterioration (−3.5 ± 9.7 vs −7.1 ± 8.7, p = 0.036, 12-month) of dominant leg extension power than non-PST
subjects. Some secondary outcomes were also improved in control groups (non-EN or non-PST). No adverse effects
were reported.
Conclusions: The three-month EN intervention resulted in short-term (3-month) frailty status improvement and
long-term effect on bone mineral density and serum vitamin D (12-month) among Taiwanese community-dwelling
elders. The effect of PST was less pronounce.
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Frailty is a geriatric condition characterized by loss of
reserves (energy, physical ability, cognition, health) that
gives rise to vulnerability [1]. The lack of a consensus,
however, on the definitions of and measurements for this
geriatric condition has limited comparisons on the effect-
iveness of interventional studies on frail older adults [2].
Numerous instruments were developed to measure frailty.
A recent review of on frailty instruments as outcome
measures found that instruments could generally fit into
3 dimensions (physical, psychological, and social) with
8 factors (nutritional status, physical activity, mobility,
energy, strength, cognition, mood, and social relationship/
social support) [3]. However, it is not clear whether these
instruments had sound clinimetric properties to be con-
sidered as good outcome measures that were responsive
to interventions [3]. Another recent review on exercise
interventions for management of frailty also pointed out
that even all 47 studied enrolled “frail” older adults, vali-
dated operationalizations of frailty were only available for
3 studies [4]. None of the studies reviewed used frailty
status as an outcome measure [4]. When we conducted a
systemic review of frailty intervention focusing on trials
that measured outcomes based on their pre-defined frailty
indicators, only 11 studies were included [5]. Of the 4
studies [2,6-8] that enrolled participants based on the
Cardiovascular Health Study Phenotypic Classification of
Frailty (CHS_PCF) [9], one have not published their
study outcome [2], and the rests [6-8] were not able to
demonstrate the effects of interventions on indicators
from the CHS_PCF.
Frailty has multiple etiologies, interacting pathogeneses,
and often linked with other geriatric conditions and poor
outcomes [10,11]. For example, a recent review found
consistent bidirectional associations between depression
and frailty in cross-sectional studies, but less consistent
associations in cohort studies [12]. Similarly, osteoporosis
and frailty shared many common risk factors — such as
malnutrition, sarcopenia, physical inactivity, and low
vitamin D [4,13-15] — that would increase the risk of
fall and fracture [14].
However, it is not clear whether interventions targeting
frailty or other geriatric conditions (eg: depression or
osteoporosis) may benefit from each other.
We designed a pilot randomized control trail using vali-
dated frailty indicators to enroll 117 community-dwelling
older adults with the following aims: 1) To determine
whether the proposed interventions may have an impact
on dynamic changes of frailty indicators. 2) To determine
whether these interventions have impacts on other out-
comes including depression, cognition, bone mineral
density, physical function, and quality of life. 3) To explore
the feasibility and accurate sample size to inform the de-
sign and implementation of future large scale clinical trial.Methods
A single site randomized controlled trial was conducted
with a 3-month interventions and a 12-month follow-up
period after baseline assessments on Taiwanese older
adults with high frailty risk (Figure 1). The study was
approved in 2008 by the Institutional Review Board of
the National Health Research Institutes (NHRI), Zhunan,
Taiwan.
Recruitment and eligibility
Participants were enrolled after a telephone interview
screening followed by a hospital screening. Our target
population was community-dwelling older adults from
65 to 79 years of age in Toufen Township (N= 6,828).
The Chinese Canadian Study of Health and Aging Clin-
ical Frailty Scale Telephone Version (CCSHA_CFS_TV)
[1,16] with satisfactory inter-rater reliability and criterion
validity was used for the first stage screening. The instru-
ment was particularly useful in population base screening
for its short administration time (<3 min) and its easy
implementation even by interviewers without formal
training in geriatric care [16]. Eligible participants were
those scored 3-6 on the CCSHA_CFS_TV. Exclusion
criteria included institutionalizations; communication
barriers; and scores of 1, 2, (too healthy) or 7 (too ill)
on the CCSHA_CFS_TV.
Eligible older adults were invited to a local community
hospital for second-stage screening during their annual
geriatric health exams that included history and physical,
blood works such as complete blood counts and blood
chemistry. Informed consents were signed after careful
explanations of the benefits and risks of proposed study.
Participants were also asked to give permissions to use
information gathered from the geriatric health exams as
well as other blood works (such as 25(OH) vitamin D),
or special tests (such as bone mineral density) needed
from the study.
The CHS_PCF was used to select eligible participants
[9]. Most cut-points were adapted from the CHS (Please
refer to Table 1 for detail). Important modifications were:
Weight loss of 3 kg (instead of 5 kg) was used to adjust
for smaller body size for an East Asian population. The
Taiwan IPAQ-SF (International Physical Activity Ques-
tionnaire Short Form) [17] instead of the Minnesota
Leisure Time Physical Activity Questionnaire [18] was
used to measure energy expenditure because the former
has been validated in Taiwanese populations [17].
Exclusion criteria included hearing/visual impairments
affecting daily activity; cognitive impairment, as defined by
a Mini-Mental Status Exam (MMSE) score of ≤16 [19];
functional impairment, as defined by a Barthel Index (BI)
≤35 [20]; active alcohol-abuse problems, organic men-
tal disorders; history of schizophrenia or a diagnosis of
a bipolar disorder; any mental problems (other than
Figure 1 Flow chart.
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Table 1 The modified Cardiovascular Health Study_ Phenotypic Classification of Frailty (CHS_PCF) criteria
Characteristics Definition
Weight loss Unintentional weight loss of more than 3 kg, or greater than 5% of body weight of the previous year
Exhaustion Based on the Center for Epidemiologic Studies Depression Scale (CES-D). Self-report of either of:
“I felt that everything I did was an effort” and “I could not get going.” were at least occasionally or more frequent
Low activity level Based on the Taiwan International Physical Activity Questionnaire Short Form (IPAQ-SF). Weekly energy expenditure
for activities ≧ 2 metabolic equivalent tasks (METs) of fewer than 383 kcal for men and 270 kcal for women
Slowness Five-meter walking time, by gender and height:
Men: time ≧7 s for height ≦ 173 cm or time ≧ 6 s for height > 173 cm
Women: time ≧ 7 s for height ≦ 159 cm or time ≧ 6 s for height > 159 cm
Weakness Grip strength (kg), 3 measurements of the dominant hand from a dynamometer (North Coast Medical
Precision Instrument, NC70142), stratified by gender and body mass index (BMI) quartiles:
Men: ≦ 29 kg for BMI ≦ 24 kg/m2, ≦30 kg for BMI 24.1-26 kg/m2, ≦30 kg for BMI 26.1-28 kg/m2,
≦32 kg for BMI > 28 kg/m2
Women: ≦ 17 kg for BMI ≦ 23 kg/m2, ≦ 17.3 kg for BMI 23.1-26 kg/m2, ≦18 kg for BMI 26.1-29 kg/m2,
≦21 kg for BMI > 29 kg/m2
Overall frailty status Robust: 0 indicator was present. Pre-frail: 1 or 2 indicators were present. Frail: ≧ 3 indicators were present
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tion; and a score of 0 on the CHS_PCF [9].
Measurements and procedures
Baseline assessments were completed before randomiza-
tions. Outcomes were assessed at the end of intervention
(roughly 3 months after baseline assessments), 6 months
and 12 months after baseline assessments.
Baseline assessments
Other than the frailty related characteristics collected
from screening stages, comprehensive assessments were
performed to collect data on several domains including
1) demographics, 2) health related characteristics, 3) body
composition, and musculoskeletal system characteristics,
and 4) blood works. Important primary and secondary
outcomes were listed below.
Primary and secondary outcomes
The primary outcome was improvement of CHS_PCF by
at least one category (from pre-frail to robust, or from
frail to pre-frail or robust) [9]. Secondary outcomes
included interval changes of the following indicators
between baseline and repeated assessments. We also
categorized secondary outcomes into the above domains.
In the frailty index domain, we included each of the 5
indicator from the CHS_PCF [9]. In the health-related
characteristics domain, we included the Mini Mental
Status Exam (MMSE) [19], Primary Care Evaluation of
Mental Disorders (PRIME-MD) score [21], and the Barthel
Index (BI) score [20], health care resource utilization, and
EQ-5DTM [22]. In the complex body composition and
musculoskeletal system domain, we included, body mass
index (BMI), fat free mass (FFM) (Inbody 3.0W, as a sub-
stitute of lean body mass), lowest T score from eitherspine or hip bone mineral density (BMD, Norland Excell
Bone DensitometerW), left one-leg-stand time, and dom-
inant leg extension power. Finally, for all the blood chem-
istry we collected, we only reported 25(OH) Vitamin D
level as the outcome for this manuscript. Most primary
and secondary outcomes were repeated at all follow up
visits except for MMSE, BMD, and 25(OH) Vitamin D
(only repeated at 12-month). To improve the compar-
ability of the baseline and 12-month 25(OH) Vitamin D
samples, we defrosted samples collected at 2 different
time-points to run the radioimmunoassay (RIA) on the
same kit (DiaSorinW, Minnesota, U.S.A.).
Randomization
Subjects were stratified by age (65-74, 75-79) and
gender to achieve balance of baseline characteristics.
Within each stratum, a permuted block (4 persons/block)
randomization method was used to ensure balanced
assignments. The randomization code was generated
from the off-site statistical center with a computer ran-
dom number generator. Random group allocation was
managed by a project manager not involved in assess-
ment or intervention. In a 2 × 2 factorial design, subjects
were first randomly assigned to an exercise and nutri-
tional program (EN) or non-EN group. Within each
group, subjects were further randomized to a problem
solving therapy (PST) [23] group or non-PST group.
Previous studies have shown that when PST was used,
both mental and physical health were improved [23].
The 2 × 2 factorial design would help to determine the
individual effect of two interventions on frailty.
Blinding
The research assistants who performed baseline and out-
come assessments were blinded from the randomization
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The educational booklet on frailty, healthy diets, exercise
protocols, and self-coping strategies was given to all par-
ticipants. Subjects who were randomized into the non-
EN, non-PST groups were contacted monthly to check
on how much they had read the booklet and how well
they had complied with the suggested diet and exercise
protocols. For those randomized into EN or PST groups,
similar questions were asked during their visits to the
study sites for their designated programs
Exercise and nutritional program
The EN group subjects were invited to take a structured
exercise course at the participating hospital 3 times a
week for 3 months. Each section lasted about 1 h. The
exercise program included 15 min warm up with 10 min
brisk walks followed by gentle stretching of major joints
(cervical and lumbar joints) and muscles (such as biceps,
triceps, hamstrings, rectus femoris, gastrocnemius, soleus)
for 5 repetitions each. Resistance training (20-30 min)
with rubber band and bottled water (0.6-1 L) as weight
for major muscles of upper and lower limbs with 10 to
15 repetitions for each (such as deltoids, biceps, triceps,
hand grasp, hip and knee flexors and extensors, hip
abductors, ankle plantar flexors and dorsiflexors). Pos-
tural control activities and balance training were also
provided for 10 min by asking participants to perform
tandem gaits and one leg standing with eyes open/close
(up to ones’ ability), step up and down stairs, toe walking
and heel walking. Finally a 5-min cool down session with
gentle relaxation movements are done. The research
team also inquired about the subjects’ dietary compliance
and responded to their dietary questions during the exer-
cise sessions.
The problem solving therapy
The PST group subjects received 6 sessions therapy by
trained case managers. It is a brief form of evidence-
based psychotherapy that was originally developed in
Britain for use by medical professionals in primary care.
It teaches people how to solve the “here-and-now”
problems contributing to their mood-related conditions
and helps increase their self-efficacy [23]. Previous stud-
ies have shown that when PST was used to manage
mental problems, both mental and physical health were
improved [23].
Approaches to analysis
Data were coded to permit blinding to group allocation
during statistical analysis. All statistical analyses wereconducted using SAS software, Version 9.1 (SAS Institute,
Inc., Cary, NC). Analysis was conducted at baseline and
at 3-month, 6-month, and 12-month follow-up assess-
ments in accord with the “intention-to-treat” principle
(ITT). Summary statistics, including mean and standard
deviation, were provided for continuous variables, such
as age, MMSE, PRIME-MD, etc. Frequencies and propor-
tions were used to summarize discrete variables, such as
CCSHA_CFS TV, CHS_PCF categorization, etc. Missing
variables were excluded from analyses. Baseline charac-
teristics were compared between two groups using t-test
for continuous variables and chi-square test with Fisher’s
exact test when appropriate for categorical variables.
Because of the factorial design, we tested for a possible
interaction between the 2 interventions (EN and PST)
for each reported outcome. If there was no interaction,
we examine the independent effect of one intervention
controlling for the effect of the other. If there was sig-
nificant interaction, we would perform subgroup analysis
to report the effect of one intervention with or without
the other intervention.
In our study, the outcomes of interest (e.g., frailty
improvement) were measured at several time points (base-
line, the 3rd month, the 6th month, and the 12th month).
For estimating the repeated measurements of the inter-
vention effect, the generalized estimating equations (GEE)
model was used to compare the between-group frailty
improvement with adjustment for time and treatment-
by-time interactions. GEE approach is an extension of
generalized linear model (GLM) and provides a semi-
parametric approach to repeated categorical response.
The intervention effect can be reasonably estimated by
using GEE even if the covariance structure is not specified
correctly. The primary outcome was also adjusted for
multiple baseline characteristics, including age, gender,
MMSE, healthcare-resource utilizations, EQ-5D, FFM,
BMD, one-leg stand and 25 (OH) Vitamin D. Where high
co-linearity was found between two potential confoun-
ders, only one variable was retained in the final model.
Longitudinal changes between groups and changes
within a group were analyzed with the use of linear
mixed models. However, the between-group BMD differ-
ences were compared using logistic regression model at
12 months. Under all circumstances, P < 0.05 was consid-
ered to be statistically significant.
Results
Participant flow
From the 6,828 target population, the probability-
proportional-to-size (PPS) sampling approach was employed
to select 2,900 population-representative random samples
for first-stage screening. However, only 845 completed
the telephone interview, 548 of whom were eligible for
second-stage screening. Half (N=275) signed the informed
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ment period was roughly 3 months. Following the 2 by
2 factorial design protocol, 117 out of the 151 eligible
subjects were randomized into 4 groups: A (EN/PST), B
(EN/non-PST), C(non-EN/PST), and D(non-EN/non-PST).
Group A and B were combined into the EN group
(N= 55) while group C and D were combined into the
non-EN group (N=62). Similarly, Group A and C became
the PST group (N= 57) while group B and D were the
non-PST group (N= 60). Eighteen of the 55 EN group
subjects attended at least 50% of the 36 intervention
sessions while 16 of the 57 PST subjects completed the
6 courses. At 12 months, 50 (EN group), 51 (non-EN
group), 48 (PST group), 53 (non-PST group) subjects
completed final assessments, respectively. The reason
for attrition was participant refusal (Figure 1).Baseline characteristics
For the entire cohort (N= 117), mean age was 71.4 ± 3.7;
and 69 (59%) were female. Using the CCSHA_CFS TV,
47 (40%) were categorized into category 3 (well, with
treated co-morbid diseases), 55 (47%) into category 4
(apparently vulnerable), 13 (11%) into category 5 (mildly
frail), and 2 (2%) into category 6 (moderately frail). With
the CHS_PCF, 102 (87%) were classified pre-frail, and
15 (13%) as frail at baseline.
Even though all subjects were considered at high risk
for frailty, subjects enrolled in the trial were relatively
healthy with few co-morbidities (3.5 ± 2.2), preserved BI
(mean 98.3 ± 4.7) score, MMSE (24.4 ± 3.9) scores, low
PRIME-MD (2.5 ± 3.4) score, satisfactory EQ-5D score
(0.9 ± 0.1), and few healthcare-resource utilizations
(1.6 ± 2.0). The cohort had high prevalence of radio-
graphic vertebral fracture (N= 111, 95%), and high preva-
lence of osteopenia (n = 92, 80%) from DXA scan. The
mean left one leg stand time was 5.8 ± 6.3 s, the mean
dominant leg extension power is 25.7 ± 6.1 kg, and the
mean 25 (OH) Vitamin D level was 17.5 ± 5.8 (ng/ml).
Most baseline characteristics were similar between EN
and no-EN group, also between PST, and non-PST group
(Table 2). However, EN group subjects had lower per-
centage of weakness (60% vs 81%, p = 0.014), higher
number of co-morbid conditions (4.0 ± 2.1 vs 3.1 ± 2.2,
p = 0.022) (Table 2). Also, PST group subjects higher
percentage of slowness (26% vs 12%, p = 0.043).Primary outcomes and transition of frailty status
The improvement rates were highest at the end of inter-
vention (3-month) for EN (45%) and PST (44%) groups.
Afterwards, there were gradual declines of the improve-
ment rates at 6 (42% EN group, 35% PST group) and
12 (40%, EN group, 35% PST group) months. On the
other hands, the improvement rates of the non-EN, ornon-PST group subjects were stable around 30%. There-
fore, only the 3-month differences between EN and non-
EN group (45% vs 27% p= 0.008) was significant after
adjusting the effect of PST and other potential confoun-
ders (Figure 2).
During the intervention period (baseline to 3-month),
33 (32.4%) of the prefrail participants (N= 102) improved
to robust, while 3 (20%) and 6(40%) of the frail (N= 15)
participants improved to robust and prefrail, respectively
(Table 3). During follow-up periods without intensive
interventions, most individual stayed at their original sta-
tus, the chances for natural transition to better frailty sta-
tus was a lot fewer. For example, during the 3-6 month
follow up period, only 2 (22.2%) of frail individuals (N=9)
improved to prefail status, and only 12 (16.7%) of prefrail
individuals (N= 72) improved to robust status.
Secondary outcomes
Individual frailty indicator
In general, no within or between group differences were
observed over repeated measures (Table 4).
Health-related characteristics
There were no observable between group changes.
However, within group improvements were found for
PRIME-MD (non-EN and PST group at 3-month), BI
(all 4 groups at 3-month), and EQ-5D (non-EN and
non-PST group at 3-month) (Table 4).
Body composition, and musculoskeletal
system characteristics
In general, there were no observable between group dif-
ferences except that changes of dominant leg extension
power at 6 and 12 months were in favor of the PST group
(both p < 0.05). At 12 month, BMI decreased in both EN
and PST group, but not the non-EN or non-PST group.
However, FFM decreased in all 4 groups. For one leg
stand time and leg extension power, changes at different
time periods were general more obvious in intervention
(EN or PST) than control (non-EN, non-PST) groups
(Table 4).
Blood test
Increase of 25 (OH) Vitamin D level was observed in
EN, PST, and non-PST groups in 12 months. The differ-
ence between EN and non-EN group (4.9 ± 7.7 vs
1.2 ± 5.4, p = 0.006) was statistically significant (Table 4).
Interaction
Interactions between EN and PST were found for
improvement of weight loss and 25 (OH) Vitamin D.
Controlling the effect of PST, the effect of EN was more
significant in EN/non-PST subgroup (weight loss), and
Table 2 Baseline Characteristics of the Participants, Total Patient Number =117
Characteristics EN (N= 55) Non-EN (N= 62) P-value{ PST (N = 57) Non-PST (N= 60) P-value{
n (%) mean ± sd† n (%) mean ± sd† n (%) mean ± sd† n (%) mean ± sd†
Frailty-Related Characteristics
CCSHA_CFS TV
well, with treated co-morbid diseases (3) 24 (44) 23 (37 ) 0.719 24 (42) 23 (38) 0.755
apparently vulnerable (4) 25 (45) 30 (48) 27 (47) 28 (7)
mildly frail (5) + moderately frail (6) 6 (11) 9 (15) 6 (11) 9 (15)
CHS_PCF categorization
pre-frail (1–2) 46 (84) 56 (90) 0.280 48 (84) 54 (90) 0.349
frail (3–5) 9 (16) 6 (10) 9 (16 ) 6 (10 )
CHS_PCF characteristics
Weight loss (yes) 18 (33) 12 (19) 0.098 12 (21 ) 18 (3) 0.268
Exhaustion (yes) 25 (45 ) 23 (37) 0.359 22 (39) 26(43) 0.603
Low activity level (yes) 3 (5) 6 (10) 0.498 5(9) 4(7) 0.739
Slowness (yes) 10(18) 12(9) 0.871 15 (26) 7 (12) 0.043
Weakness (yes) 33 (60) 50 (81) 0.014 42 (74) 41 (68) 0.524
Demographics
Age (y/o) 70.9 ± 3.7 71.9 ± 3.7 0.158 71.5 ±3.7 71.3 ± 3.9 0.673
Female sex 33(60) 36(58) 0.832 33(58) 36 (60) 0.817
Health-Related Characteristics
Number of chronic conditions}(N = 114) 4.0 ± 2.1 3.1 ± 2.2 0.022 3.8 ± 2.4 3.2 ± 1.9 0.184
MMSE 24.8 ± 3.9 24.1 ± 3.9 0.358 24.7 ± 3.8 24.2 ± 4.0 0.552
PRIME-MD 2.1 ± 3.2 2.8 ± 3.5 0.229 2.7 ± 3.3 2.3 ± 3.4 0.469
Barthel Index 98.8 ± 3.7 97.9 ± 5.4 0.284 98.2 ± 5.4 98.4 ± 4.0 0.846
EQ-5D 0.94 ± 0.08 0.94 ± 0.08 0.969 0.95 ± 0.08 0.93 ± 0.08 0.246
Healthcare-resource utilization 1.5 ± 1.7 1.7 ± 2.2 0.517 1.6 ± 1.7 1.7 ± 2.2 0.846
Body Composition, and Musculoskeletal System Characteristics
BMI (kg/m2) 25.0 ± 3.3 25.8 ± 3.9 0.229 25.0 ± 3.8 25.8 ± 3.5 0.251
FFM (kg) 42.3 ± 7.0 43.6 ± 7. 9 0.345 42.2 ± 7.3 43.7 ± 7.6 0.275
Compres sion Fracture form Spine XRAY 53 (96) 58 (94) 0.683 54 (95) 57 (95) 1.000
BMD (T-score)k (N = 115)
> −1 13 (25) 10(16) 0.262 13 (23) 10(17) 0.401
≦ −1 40 (75) 52 (84) 43 (77) 49 (83)
Left one leg stand time (sec) (N = 111) 5.7 ± 6.9 5.8 ± 5.9 0.949 5.3 ± 6.7 6.2 ± 6.0 0.483
Dominant leg extension power (kg) 26.3 ± 5.1 25.2 ± 6.8 0.295 23.9 ± 6.5 27.4 ± 5.1 0.002
Blood Examination
25(OH) Vitamin D (ng/mL) (N = 109) 17.8 ± 5.3 17.2 ± 6.2 0.558 17.9 ± 5.5 17.2 ± 6.0 0.514
†:Categorical data:n (%);Continuous variables:mean ± sd.
{:Categorical data:χ2 test or Fisher’s exact test;Continuous variables: t-test.
}:From 27 diseases.
}:Emergency room visits, hospitalizations, or clinic visits in the past 3 months.
k:The minimum T-score of either the femoral neck or the spinal mean at L2–L4.
BMD:Bone Mineral Density, BMI: Body mass index, CCSHA_CFS TV:Chinese Canadian Study of Health and Aging_Clinical Frailty Scale Telephone Version, CHS_PCF:
Cardiovascular Health Study_Phenotypical Classifica tion of Frailty, EN:Exercise and Nutrition, EQ-5D:EuroQol Quality of Life Scale, FFM:Fat Free Mass,
MMSE:Mini-Mental State Examination, PRIME-MD:Primary Care Evaluation of Mental Disorders, PST:Problem Solving Therapy.
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Figure 2 Primary Outcome.
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Table S1). Controlling for the effect of EN, the effect of
PST was more significant in PST/EN subgroup (for both
variables) (Additional file 2: Table S2).
Discussion
Our study demonstrates that the three-month exercise
and nutritional program resulted in short-term (3-month)
frailty status improvement and long-term effect on BMD
and serum 25 OH Vitamin D (12-month) among a
population-representative sample of frail older adults. The
effect of PST on geriatric frailty, mood, and physical per-
formance was less pronounce. We also found some signifi-
cant improvements in the control (non-EN, non-PST)
groups.
Many instruments were created to measure frailty and
studies with different instruments were difficult to com-
pare with [24]. We chose several recent intervention trials
that used modified CHS_PCF for comparison [2,6-8].Table 3 Transitions among frailty states at different time
points
Baseline to 3 months 3 to 6 months 6 to 12 months
Transition No. Rate,% No. Rate,% No. Rate,%
Robust to - - N = 36 N= 34
Robust - - 22 61.1 25 73.5
Pre-frail - - 13 36.1 9 26.5
Frail - - 1 2.8 0 0.0
Pre-frail to N= 102 N= 72 N= 69
Robust 33 32.4 12 16.7 10 14.5
Pre-frail 66 64.7 54 75.0 58 84.1
Frail 3 2.9 6 8.3 1 1.4
Frail to N= 15 N= 9 N= 14
Robust 3 20.0 0 0.0 0 0.0
Pre-frail 6 40.0 2 22.2 3 21.4
Frail 6 40.0 7 77.8 11 78.6Peterson et al. enrolled 81 older male veterans scored ≥1
on CHS_PCF. Roughly half (N= 39) were randomized
into a high intensity physical activity telephone counsel-
ing group [7]. After 6-months, 49% and 69% were still
classified as frail respectively (p = 0.08). Kenny and col-
league reported the effect of 12-month transdermal tes-
tosterone patch on 131 older men with low testosterone
level, fracture, or low BMD and scored ≥1 on CHS_PCF
[6]. Improvements of BMD, and lean mass were found,
but not physical performance or frailty indicators [6]. In
another RCT, Li et al. enrolled 310 community-dwelling
older adults who scored ≥1 on the CHS_PCF [8]. The
6-month individualized multi-factorial care plans after
comprehensive geriatric assessments (CGAs) did not
improve frailty status. The Frailty Intervention Trial
(FIT) [2] used similar CGA with individualized care plans
approach but enrolled older adults with ≥3 deficiencies;
that study is still in progress and so still lacks published
outcome data. To our knowledge, ours is the first
study to demonstrate that the CHS_PCF categorization
is responsive to intervention to with sound clinimetric
properties as an outcome measure [24].
When other frailty indicators were considered, several
recent reviews found that structured exercise improved
physical and psychological determinants, frailty status,
and prevented disability in frail older adults [4,5,25,26].
However, many researchers called for more unified def-
inition and operationalization of frailty to enhance com-
parability of different intervention trials [2,4,5,27].
Expert opinions and the results of clinical trials sug-
gest nutritional consultation as a component in frailty
interventions [2,28,29]; but rarely does it stand as an
independent intervention on frailty. One recent study
showed that diet and exercise was more effective than
diet or exercise alone in improving frailty indicators
among 93 obese and frail older adults [29]. Our study
also added new evidence that combination of exercise
program and nutritional information had positive impact
on frailty.
Table 4 Follow-up analysis (Intent to treat), Total Patient Number = 117
Characteristics EN (N= 55) Non-EN (N= 62) p-value{ PST (N= 57) Non-PST (N =60) p-value{
n (%).mean ± sd† n (%) mean ± sd† n (%)mean ± sd† n (%) mean ± sd†
Frailty-related Characteristics
Improvement of CHS_PCF characteristics}
Weight loss (yes)
Improvement at 3-month 9 (16) 6 (10) 0.277 7 (12) 8 (13) 0.838
Improvement at 6-month 8 (15) 8 (13) 0.761 6 (11) 10 (17) 0.329
Improvement at 12-month 11 (20) 9 (15) 0.400 8 (14) 12 (20) 0.372
Exhaustion (yes)
Improvement at 3-month 16 (29) 17 (27) 0.824 16 (28) 17(28) 0.968
Improvement at 6-month 17 (31) 18(29) 0.806 16 (28) 19 (42) 0.666
Improvement at 12-month 19 (35) 20 (32) 0.769 16 (28) 23 (38) 0.328
Low activity level (yes)
Improvement at 3-month 2(4) 4 (6) 0.495 3(5) 3(5) 0.926
Improvement at 6-month 2 (4) 4 (6) 0.495 3 (5) 3 (5) 0.926
Improvement at 12-month 2(4) 4 (6) 0.495 3(5) 3 (5) 0.926
Slowness (yes)
Improvement at 3-month 6 (11) 2 (3) 0.126 5 (9) 3 (5) 0.423
Improvement at 6-month 4 (7) 3 (5) 0.585 6 (11) 1 (2) 0.085
Improvement at 12-month 6 (11) 3 (5) 0.232 7 (12) 2 (3) 0.090
Weakness (yes)
Improvement at 3-month 11 (20) 17 (27) 0.346 17 (30) 11 (18) 0.135
Improvement at 6-month 9 (16) 16 (26) 0.218 9 (16) 16 (27) 0.170
Improvement at 12-month 7 (13) 17 (27) 0.055 12 (21) 12 (20) 0.837
Health-Related Characteristics
MMSE
Change at 12-month −0.15 ± 2.53 0.06 ± 2.52 0.658 −0.05 ± 2.35 −0.02 ± 2.69 0.954
PRIME-MD
Change at 3-month −0.96 ± 2.92 −1.29 ± 4.50** 0.631 −1.32 ± 3.64* −0.97 ± 4.03 0.603
Change at 6-month −0.05 ± 2.84 −0.65 ± 4.03 0.356 −0.42 ± 2.96 −0.32 ± 4.00 0.846
Change at 12-month −0.16 ± 3.17 −0.77 ± 3.65 0.327 −0.77 ± 3.27 −0.22 ± 3.58 0.365
Barthel Index
Change at 3-month 1.09 ± 3.81* 1.53 ± 4.11** 0.520 1.05 ± 3.98* 1.58 ± 3.96** 0.458
Change at 6-month 0.36 ± 2.33 0.73 ± 4.78 0.597 0.88 ± 4.13 0.25 ± 3.50 0.354
Change at 12-month 0.55 ± 2.99 0.89 ± 3.68 0.617 0.88 ± 3.29 0.58 ± 3.46 0.655
EQ-5D
Change at 3-month 0.02 ± 0.08 0.03 ± 0.08* 0.632 0.01 ± 0.09 0.03 ± 0.08** 0.162
Change at 6-month −0.004 ± 0.12 0.004 ± 0.12 0.738 0.0001 ± 0.09 0.001 ± 0.14 0.980
Change at 12-month 0.01 ± 0.09 0.02 ± 0.10 0.455 0.01 ± 0.07 0.02 ± 0.11 0.534
Healthcare-resource utilization
Change at 3-month 0.04 ± 1.36 −0.35 ± 2.70 0.353 −0.07 ± 1.67 −0.27 ± 2.58 0.650
Change at 6-month 0.60 ± 1.81 0.03 ± 2.55 0.186 0.42 ± 1.74 0.18 ± 2.65 0.589
Change at 12-month 0.05 ± 1.8 0.03 ± 2.44 0.984 0.39 ± 2.05 −0.28 ± 2.25 0.104
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Table 4 Follow-up analysis (Intent to treat), Total Patient Number = 117 (Continued)
Body Composition, and Musculoskeletal System Characteristics
BMI (kg/m2)
Change at 12-month −0.31 ± 1.19* −0.18 ± 1.05 0.572 −0.36 ± 1.15* −0.13 ± 1.08 0.280
FFM (kg)
Change at 12-month −0.46 ± 1.36* −0.62 ± 1.84** 0.587 −0.59 ± 1.30** −0.50 ± 1.90* 0.726
Compression Fracture form Spine X-ray
12-month 55(100) 58(94) 0.137 54 (95) 59(98) 0.518
BMD (T-score)k (N = 115)
12-month
> −1 14(26) 7(11) 0.042 11(20) 10(17) 0.770
≦ −1 39(74) 55(89) 45(80) 49 (83)
Left one leg stand time (sec) (N = 111)
Change at 3-month 2.86 ± 9.19* 0.92 ± 9.01 0.268 2.38 ± 8.91 1.34 ± 9.34 0.553
Change at 6-month 2.57 ± 8.39* 1.81 ± 8.47 0.683 3.10 ± 8.93* 1.30 ± 7.84 0.298
Change at 12-month 3.69 ± 9.15** 3.43 ±9.15** 0.906 4.31 ± 10.23*** 2.84 ± 7.92* 0.399
Dominant leg extension power (kg)
Change at 3-month 3.06 ± 7.13** 1.72 ± 6.6* 0.330 3.42 ± 7.36*** 1.33 ± 6.32 0.102
Change at 6-month 1.48 ± 5.9 1.35 ± 7.00 0.986 2.71 ± 6.08** 0.18 ± 6.68 0.035
Change at 12-month −6.44 ± 10.08*** −4.44 ± 8.59*** 0.217 −3.52 ± 9.65** −7.14 ± 8.74*** 0.036
Blood Examination
25(OH) Vitamin D (ng/mL) (N = 109)
Change at 12-month 4.85 ± 7.69*** 1.19 ± 5.41 0.006 3.4 ± 7.80*** 2.49 ± 5.85** 0.633
*P-value < 0.05, ** p-value < 0.01, *** p-value < 0.001 for the comparison of the value at the follow-up time with the baseline value within the group, as calculated
with the use of linear mixed model.
†:Categorical data:n (%);Continuous variables:mean ± sd.
{: Intervention effect, controlling for the other treatment strategy, follow up time and treatment-by-follow up time interactions. Categorical data:generalized
estimating equations (GEE);Continuous variables:linear mixed model. P-values for compression fracture form spine XRAY and BMD from logistic regression model
with exact modification when appropriate.
}:After intervention 3, 6 and 12 months[CHS_PCF]has progressed from[yes]to[no].
}:Emergency room visits, hospitalizations, or clinic visits in the past 3 months.
k:The minimum T-score of either the femoral neck or the spinal mean at L2–L4.
BMD:Bone Mineral Density, BMI: Body mass index, CHS_PCF: Cardiovascular Health Study_Phenotypical Classification of Frailty, EN:Exercise and Nutrition, EQ-5D:
EuroQol Quality of Life Scale, FFM: Fat Free Mass, MMSE: Mini-Mental State Examination, PRIME-MD: Primary Care Evaluation of Mental Disorders, PST: Problem
Solving Therapy.
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sultation has a positive impact on BMD or 25 (OH) Vita-
min D level among frail older adults. In a study of 65
subjects randomized to moderate-intensity on-site exercise
training 3 times per week for 9 months,, the subjects’ BMD
did not differ from that of 47 subjects randomized to a low-
intensity home exercise program [30]. Similar to our study,
Villareal and colleagues reported positive effect of diet and
exercise on improving or preserving BMD from 2 RCTs of
27 [31] and 93 [29] obese older adults. This research group
[31] also found that diet and exercise increased the serum
25(OH) Vitamin D level as in our study.
In our study, subjects in the PST group had better
improvement in frailty and PRIME-MD scores than
subjects in the non-PST group; but the differences did
not reach statistical significance. Even roughly 40%
reported exhaustion from the (CES-D) [32] questions,their mean PRIME-MD score was quite low (average 2
points) indicating low level of depression. The floor effect
might explain parts of the lack of effectiveness of PST.
Some observational studies suggested that frailty is a
dynamic process and natural transitions to better status
may occur without interventions [33-35]. During the
intervention period, our degrees of improvement in
frailty status were significantly higher than the natural
improvement rates reported from observational studies
[34]. On the other hand, the improvement rates during
the follow up periods were similar to other studies [34].
It was encouraging that frailty status could be reversed
with proper interventions. However, the effects might not
last long when intensive interventions were discontinued.
We felt it unethical to enroll older adults in the control
group without basic education material to teach them about
self-managements even this might mitigate intervention
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terial only also had improvements in functional status,
mood, quality of life, and physical performance.
Strengths and limitations of the current study
The probability sampling design enhances the generali-
zability of this study to community-dwelling frail older
adults without significant cognitive or functional impair-
ments. The quick and valid CCSHA_CFS TV saved us
tremendous time and resources in conducting the large-
scale community-based frailty screening. Our educa-
tional material and interventions would be easily replic-
able in other settings.
The study also has several important limitations. First,
we encountered an unexpectedly low response rate during
the telephone-interview stage, with one-third not being
reachable after multiple attempts, and another one-third
refusing the telephone interviews, which hampers the
external validity of the current study.
Second, compliance with the thrice-weekly exercise
sessions and PST sessions were fair. Many participants
had problems reaching the study site and other personal
issues, such as taking care of their grandchildren which
prevented them from on-site intervention. The interven-
tion effect could have been enhanced if better adherence
had been reached.
Third, the CHS_PCF instrument does not allow assess-
ment of different degrees of frailty as the CCSHA_CFS_TV.
However, we were not able to detect more subtle changes
frailty degrees with the later instrument since it was only
used at the screening stage.
Forth, we did not have use population specific cut-
points in the 5 frailty indicators to enroll study partici-
pants. At the time of the study design, Taiwanese frailty
cut-points with the CHS_PCF were not available. How-
ever, since it is an interventional study with a purpose to
identify subjects with certain degree of frailty suitable for
interventions, it probabably did not matter which cut-
points were used as long as study populations could be
clearly and systemicly identified and classified.
Finally, the study sample size is relatively small, though
it is comparable or greater than some previous interven-
tional studies of frailty [6,7,28-31]. In the review con-
ducted by Thou and colleagues [4], only 13 out of 47
exercise programs had sample size greater than our study
which indicating the difficulty enrolling and conducting
RCTs in frail older adults. Since there was a lack of previ-
ous data to guide estimation of sample size based on our
designated primary outcome, one purpose of this study
was to determine feasible sample size for future study.
Conclusions
In summary, with proper exercise and nutritional man-
agement even a short, 3-month intervention can improvethe dynamic frailty process, bone mineral density, and
25(OH) Vitamin D level in frail older adults.
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